DE102013225616A1 - Antiperspirant cosmetic products containing lysozyme and / or bovine serum albumin and / or yoghurt protein - Google Patents

Abstract

The present invention relates to an antiperspirant cosmetic composition comprising a) at least one substance selected from the group of cosmetic oils which are liquid at 20 ° C. and 1013 hPa, fragrances and waxes, b) at least one antiperspirant aluminum salt in a total amount of 0 , 1 to 80 wt .-%, based on the total weight of the antiperspirant cosmetic agent, and c) lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein, wherein the addition of lysozyme and / or bovine serum albumin (BSA ) and / or yogurt protein results in effective closure of the ducts of the sweat gland (s).

Description

The present invention relates to an antiperspirant cosmetic agent which contains at least one antiperspirant aluminum salt and lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein and wherein the addition of the lysozyme and / or bovine serum albumin (BSA) and / or Yoghurt protein results in an increase in the closure of the sweat gland (s) and / or in a closure formation of the sweat gland (s).

Furthermore, the present invention relates to the use of a combination of at least one antiperspirant aluminum salt and lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein for the reduction and / or prevention of axillary sweat.

Moreover, the present invention relates to a non-therapeutic cosmetic method for preventing and / or reducing transpiration of the body, in which the antiperspirant according to the invention is applied to the skin, in particular to the skin of the armpits.

Finally, the present invention relates to the use of lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein for enhancing closure of the sweat gland (s) and / or occluding the sweat gland (s).

Washing, cleansing and caring for one's own body is a basic human need, and modern industry is constantly trying to meet these needs of man in a variety of ways. Especially important for daily hygiene is the permanent elimination or at least reduction of body odor and underarm wetness. Numerous specific deodorant or antiperspirant personal care products are known in the art which have been developed for use in body regions having a high density of sweat glands, especially in the underarm area. These are formulated in a wide variety of dosage forms, for example as powder, in stick form, as aerosol spray, pump spray, liquid and gel roll on application, cream, gel and as impregnated flexible substrates (towels).

Prior art cosmetic antiperspirants contain at least one antiperspirant salt in addition to at least one oil or fatty substance and one perfume component or perfume.

The antiperspirant salts used in antiperspirants reduce the sweat secretion of the body by a temporary narrowing or blockage of the excretory ducts of the sweat glands, so that the amount of sweat can be reduced by about 20 to 60 percent. On the other hand, they have an additional deodorizing effect due to their antimicrobial effect.

As antiperspirant salt are usually activated basic aluminum and aluminum zirconium halides, as in the references EP 0 308 937 A2 . EP 0 183 171 A2 . US 4,359,456 A and EP 0 191 628 described, used. Furthermore, it is also possible to use aluminum and aluminum zirconium halides which are stabilized with organic acids as complex ligands, as described, for example, in the publications US 3,542,919 A . US 3,553,316 . US Pat. No. 3,991,176 A and WO 2005/092795 A1 are disclosed.

A disadvantage of the aforementioned activated basic aluminum and aluminum zirconium halides of the prior art is the decrease in the antiperspirant effect with increasing storage time and / or when using protic solvents, so that a significant reduction in the sweat secretion of the body by the temporary constriction and / or constipation of the ducts of the sweat glands can not always be ensured.

There is therefore a need for antiperspirant cosmetic agents which have no significant decrease in antiperspirant activity even during long periods of storage and / or when using high levels of protic solvents. Furthermore, the antiperspirants should be inexpensive to produce.

The present invention has for its object to provide a antiperspirant cosmetic agent which avoids the disadvantages of the prior art or at least mitigates and which ensures a reliable blockage of the excretory ducts of the sweat glands even during prolonged storage periods and / or in the presence of protic solvents.

It has now surprisingly been found that the use of lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein in cosmetic agents containing antiperspirant aluminum salts leads to a significantly increased hydrogel formation in the excretory ducts of the sweat glands and thus an effective constipation ensures this excretory ducts. Hydrogel formation is extremely pH-selective and occurs only at pH levels prevalent only in the excretory ducts of the sweat glands. Due to this pH-selective hydrogel formation, a reduced antiperspirant effect due to hydrogel formation in the antiperspirant or on the skin surface is avoided and at the same time an excellent antiperspirant effect is ensured.

• a) mindestens einen Stoff, ausgewählt aus der Gruppe von kosmetischen Ölen, welche bei 20 °C und 1.013 hPa flüssig sind, Riechstoffen und Wachsen,
• b) mindestens ein schweißhemmendes Aluminiumsalz in einer Gesamtmenge von 0,1 bis 80 Gew.-%, bezogen auf das Gesamtgewicht des schweißhemmenden kosmetischen Mittels, und
• c) Lysozym und/oder Bovine serum albumin (BSA) und/oder Yoghurt Protein.

The subject of the present invention is thus an antiperspirant cosmetic containing

• a) at least one substance selected from the group of cosmetic oils which are liquid at 20 ° C. and 1013 hPa, fragrances and waxes,
• b) at least one antiperspirant aluminum salt in a total amount of 0.1 to 80 wt .-%, based on the total weight of the antiperspirant cosmetic agent, and
• c) lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein.

By combining antiperspirant aluminum salts with lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein, hydrogel formation of the antiperspirant aluminum salt with lysozyme and / or, without wishing to be limited to this theory, occurs exclusively at extremely specific pH values Bovine serum albumin (BSA) and / or yogurt protein. Due to the extremely selective formation of the hydrogel at pH values, which are exclusively within the excretory ducts of the sweat glands, an effective blockage of the excretory ducts of the sweat glands is ensured without the antiperspirant effect of the cosmetic product according to the invention due to premature undesired hydrogel formation due to the addition of lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein and / or yogurt protein is decreased. Thus, even after prolonged storage periods and / or the presence of high levels of protic solvents, an excellent antiperspirant effect can be ensured.

The term "antiperspirant" is understood according to the invention to reduce or reduce the perspiration of the sweat glands of the body.

Furthermore, the term "cosmetic oil" in the context of the present invention is understood to mean an oil which is suitable for cosmetic use and which is immiscible with water. Furthermore, the cosmetic oil used according to the invention is neither fragrances nor essential oils.

In addition, the term "fragrances" in the context of the present invention means substances having a molecular weight of 74 to 300 g / mol, which contain at least one osmophoric group in the molecule and have an odor and / or taste, d. H. they are able to excite the receptors of the hair cells of the olfactory system. Osmophore groups are covalently bonded to the molecular skeleton groups in the form of hydroxyl groups, formyl groups, oxo groups, alkoxycarbonyl groups, nitrile groups, nitro groups, azide groups, etc. In this context, the term "fragrances" within the meaning of the present invention also at 20 ° C and 1013 hPa liquid perfume oils, perfumes, or perfume oil ingredients.

In addition, the term "waxes" in the context of the present invention means substances which are kneadable at 20 ° C or solid to brittle hard, have a coarse to finely crystalline structure and color translucent to opaque, but not glassy. Furthermore, these substances melt above 25 ° C without decomposition, are slightly above the melting point slightly liquid (less viscous), have a strong temperature-dependent consistency and solubility and are polishable under light pressure.

The term "volatile cosmetic oil" refers according to the invention to cosmetic oils which have a vapor pressure of from 2.66 Pa to 40,000 Pa (0.02 to 300 mm Hg), preferably from 10 to 12,000 Pa, at 20 ° C. and an ambient pressure of 1013 hPa ( 0.1 to 90 mm Hg), more preferably from 13 to 3000 Pa (0.1 to 23 mm Hg), in particular from 15 to 500 Pa (0.1 to 4 mm Hg).

In addition, the term "nonvolatile cosmetic oils" in the context of the present invention means cosmetic oils which have a vapor pressure of less than 2.66 Pa (0.02 mm Hg) at 20 ° C. and an ambient pressure of 1013 hPa.

Furthermore, the term "fatty acid" as used in the context of the present invention means aliphatic carboxylic acids which have unbranched or branched carbon radicals having 4 to 40 carbon atoms. The fatty acids used in the present invention may be both naturally occurring and synthetically produced fatty acids. Furthermore, the fatty acids may be monounsaturated or polyunsaturated.

Finally, the term "fatty alcohol" in the context of the present invention means aliphatic, monohydric, primary alcohols which have unbranched or branched hydrocarbon radicals having from 4 to 40 carbon atoms. The fatty alcohols used in the invention may also be monounsaturated or polyunsaturated.

The statement wt .-% refers in the present case, unless otherwise stated, on the total weight of the antiperspirant cosmetic agents according to the invention without any optional propellant.

• (i) flüchtigen cyclischen Siliconölen, insbesondere Cyclotrisiloxan, Cyclotetrasiloxan, Cyclopentasiloxan und Cyclohexasiloxan, und linearen Siliconölen mit 2 bis 10 Siloxaneinheiten, insbesondere Hexamethyldisiloxan, Octamethyltrisiloxan, Decamethyltetrasiloxan;
• (ii) flüchtigen Nichtsiliconölen, insbesondere flüssigen Paraffinölen und Isoparaffinölen, wie Isodecan, Isoundecan, Isododecan, Isotridecan, Isotetradecan, Isopentadecan, Isohexadecan und Isoeicosan;
• (iii) nichtflüchtigen Siliconölen, insbesondere höhermolekularen linearen Polyalkylsiloxane;
• (iv) nichtflüchtigen Nichtsiliconölen, insbesondere den Estern von linearen oder verzweigten gesättigten oder ungesättigten C_2-30-Fettalkoholen mit linearen oder verzweigten gesättigten oder ungesättigten C_2-30-Fettsäuren, welche hydroxyliert sein können, den C₈-C₂₂-Fettalkoholestern einwertiger oder mehrwertiger C₂-C₇-Hydroxycarbonsäuren, den Triethylcitraten, den verzweigten gesättigten oder ungesättigten C_6-30-Fettalkoholen, den Mono-, Di- und Triglyceriden von linearen oder verzweigten, gesättigten oder ungesättigten, gegebenenfalls hydroxylierten C₈-₃₀-Fettsäuren, den Dicarbonsäureestern von linearen oder verzweigten C₂-C₁₀-Alkanolen, den Anlagerungsprodukten von Ethylenoxid und/oder Propylenoxid an ein- oder mehrwertige C_3·22-Alkanole, welche gegebenenfalls verestert sein können, den symmetrischen, unsymmetrischen oder cyclischen Estern der Kohlensäure mit Fettalkoholen, den Estern von Dimeren ungesättigter C_12-22-Fettsäuren mit einwertigen, linearen, verzweigten und cyclischen C_2-18-Alkanolen oder C_2-6-Alkanolen, den Benzoesäureestern von linearen oder verzweigten C_8-22-Alkanolen, wie Benzoesäure-C_12-15-Alkylester und Benzoesäureisostearylester und Benzoesäureoctyldodecyl-ester, den synthetischen Kohlenwasserstoffen, wie Polyisobuten und Polydecene, den alicyclischen Kohlenwasserstoffen; sowie
• (v) deren Mischungen.

According to a preferred embodiment of the present invention, the cosmetic oil which is liquid at 20 ° C and 1013 hPa is selected from the group of

• (i) volatile cyclic silicone oils, especially cyclotrisiloxane, cyclotetrasiloxane, cyclopentasiloxane and cyclohexasiloxane, and linear silicone oils having 2 to 10 siloxane units, especially hexamethyldisiloxane, octamethyltrisiloxane, decamethyltetrasiloxane;
• (ii) volatile non-silicone oils, especially liquid paraffin oils and isoparaffin oils such as isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane and isoeicosan;
• (iii) nonvolatile silicone oils, especially higher molecular weight linear polyalkylsiloxanes;
• (iv) non-volatile non-silicone oils, in particular esters of linear or branched C _2-30 saturated or unsaturated fatty alcohols with linear or branched C _2-30 saturated or unsaturated fatty acids which may be hydroxylated, monohydric C ₈ -C ₂₂ fatty alcohol esters or polyhydric C ₂ -C ₇ hydroxycarboxylic acids, the triethyl citrates, the branched saturated or unsaturated C _6-30 fatty alcohols, the mono-, di- and triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C ₈ - ₃₀ fatty acids , the dicarboxylic acid esters of linear or branched C ₂ -C ₁₀ -alkanols, the addition products of ethylene oxide and / or propylene oxide to mono- or polyhydric C _{3 · 22} -alkanols, which may optionally be esterified, the symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, the esters of dimers of unsaturated C _12-22 fatty acids with one way linear, branched and cyclic C _2-18 -alkanols or C _2-6 -alkanols, the benzoic acid esters of linear or branched C _8-22 -alkanols, such as C _12-15 -alkyl benzoate and isostearyl benzoate and octyl-dodecylbenzoate, the synthetic hydrocarbons, such as polyisobutene and polydecenes, the alicyclic hydrocarbons; such as
• (v) their mixtures.

The use of volatile silicone oils and volatile non-silicone oils in the antiperspirant cosmetic agents of the present invention results in a drier skin feel and faster release of the antiperspirant aluminum salt.

The cyclic volatile silicone oils which can be used in the context of the invention have a vapor pressure of from 13 to 15 Pa (0.1 mm Hg) at 20 ° C. and an ambient pressure of 1013 hPa. Furthermore, according to the invention as a linear volatile silicone oil and a low molecular weight phenyl trimethicone having a vapor pressure of about 2,000 Pa (15 mm Hg) at 20 ° C and an ambient pressure of 1013 hPa can be used. However, due to the high persistence of cyclodimethicones in the environment, it may be preferred according to the invention if 0 to less than 1 wt .-%, preferably 0 to less than 0.1 wt .-%, cyclic volatile silicone oils used in the antiperspirant cosmetic agents according to the invention become.

According to the invention, volatile non-silicone oils in the form of C _10-13 isoparaffin mixtures having a vapor pressure of from 10 to 400 Pa (0.08 to 3 mm Hg), preferably from 13 to 100 Pa (0.1 to 0.8 mm Hg ), used at 20 ° C and an ambient pressure of 1013 hPa. It is preferred in the context of the present invention, if the volatile C ₈ -C ₁₆ isoparaffin in a total amount of 1 to 60 wt .-%, preferably from 3 to 45 wt .-%, preferably from 5 to 40 parts by weight. %, in particular from 8 to 20 wt .-%, based on the total weight of the antiperspirant cosmetic agent is included. Of course, it is also possible, according to the invention antiperspirant cosmetic products with a low proportion of volatile oils - that is, with 0.5 to 15 wt .-%, based on the total weight of the antiperspirant cosmetic agent, on volatile oils - or even without volatile oils to formulate.

In order to mask insoluble constituents, such as talc or antiperspirant aluminum salts which have been dried on the skin, it may be preferred according to the invention if the antiperspirant cosmetic agents comprise a non-volatile silicone oil and / or a non-volatile non-silicone oil.

In this context, preferred antiperspirant cosmetic agents according to the invention contain at least one ester of linear or branched saturated or unsaturated fatty alcohols having 2 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2 to 30 carbon atoms, which may be hydroxylated, in a total amount of 1 to 30 wt .-%, preferably from 5 to 26 wt .-%, preferably from 9 to 24 wt .-%, in particular from 12 to 17 wt .-%, based on the total weight of the antiperspirant cosmetic agent.

In the context of the present invention, non-volatile silicone oils may be linear polyalkylsiloxanes having a kinematic viscosity of from 5 to 2,000 cSt at 25 ° C., in particular linear polydimethylsiloxanes having a kinematic viscosity at 25 ° C. of from 5 to 2,000 cSt, preferably from 10 to 350 cSt, in particular from 50 to 100 cSt. The non-volatile silicone oils mentioned above are available under the tradenames Dow Corning ^® 200 or Xiameter PMX from Dow Corning or Xiameter. Further preferred nonvolatile silicone oils are phenyltrimethicones having a kinematic viscosity at 25 ° C. of from 10 to 100 cSt, preferably from 15 to 30 cSt, and also cetyldimethicones.

Further preferred according to the invention is the use of mixtures of the abovementioned cosmetic oils, in particular nonvolatile and volatile cosmetic oils, since in this way parameters such as skin feel, visibility of the residue and stability of the antiperspirant cosmetic agent according to the invention are adjusted and the agent is thus better suited to the needs of the invention Consumer can be adjusted.

For the purposes of the present invention, it is preferred if the cosmetic oil which is liquid at 20 ° C. and 1013 hPa is present in a total amount of from 1 to 95% by weight, preferably from 10 to 85% by weight, preferably from 20 to 75% by weight. -%, more preferably from 35 to 70 wt .-%, in particular from 50 to 60 wt .-%, based on the total weight of the antiperspirant cosmetic agent is included.

However, it may also be preferred if the liquid cosmetic oil at 20 ° C and 1013 hPa in a total amount of 0.2 to 70 wt .-%, preferably from 2 to 60 wt .-%, preferably from 3 to 50 wt. -%, more preferably from 5 to 35 wt .-%, in particular from 8 to 20 wt .-%, based on the total weight of the antiperspirant cosmetic agent is included. In this context, it can also be provided according to the invention that the antiperspirant compositions according to the invention less than 0.2 wt .-%, preferably less than 0.1 wt .-%, in particular 0 wt .-% of at 20 ° C and 1013 hPa containing liquid cosmetic oil. The use of only extremely small amounts of the cosmetic oil which is liquid at 20 ° C. and 1013 hPa is particularly preferred in the case of antiperspirant cosmetic agents according to the invention which are present in aqueous, aqueous-alcoholic or aqueous-glycolic form.

• (i) Estern, insbesondere Benzylacetat, Phenoxyethylisobutyrat, p-tert.-Butylcyclohexylacetat, Linalylacetat, Dimethylbenzylcarbinylacetat (DMBCA), Phenylethylacetat, Benzylacetat, Ethylmethylphenylglycinat, Allylcyclohexylpropionat, Styrallylpropionat, Benzylsalicylat, Cyclohexylsalicylat, Floramat, Melusat und Jasmecyclat;
• (ii) Ethern, insbesondere Benzylethylether und Ambroxan;
• (iii) Aldehyden, insbesondere linearen Alkanale mit 8 bis 18 Kohlenstoffatomen, Citral, Citronellal, Citronellyloxy-acetaldehyd, Cyclamenaldehyd, Lilial und Bourgeonal;
• (iv) Ketonen, insbesondere Jonone, alpha-Isomethylionon und Methylcedrylketon;
• (v) Alkoholen, insbesondere Anethol, Citronellol, Eugenol, Geraniol, Linalool, Phenylethylalkohol und Terpineol;
• (vi) Kohlenwasserstoffen, insbesondere Terpene wie Limonen und Pinen; sowie
• (vii) deren Mischungen.

According to a preferred embodiment of the present invention, the fragrance is selected from the group of

• (i) esters, especially benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinylacetate (DMBCA), phenylethylacetate, benzylacetate, ethylmethylphenylglycinate, allylcyclohexylpropionate, styrallylpropionate, benzylsalicylate, cyclohexylsalicylate, floramate, melusate and jasmecyclate;
• (ii) ethers, especially benzyl ethyl ether and ambroxan;
• (iii) aldehydes, especially linear alkanals of 8 to 18 carbon atoms, citral, citronellal, citronellyloxy-acetaldehyde, cyclamen aldehyde, lilial and bourgeonal;
• (iv) ketones, especially ionone, alpha-isomethylionone and methyl cedryl ketone;
• (v) alcohols, especially anethole, citronellol, eugenol, geraniol, linalool, phenylethyl alcohol and terpineol;
• (vi) hydrocarbons, in particular terpenes such as limonene and pinene; such as
• (vii) their mixtures.

However, mixtures of different fragrances are preferably used, which together produce an appealing scent.

Particularly pleasing antiperspirant cosmetic agents according to the invention are obtained when the perfume in a total amount of 0.00001 to 10 wt .-%, preferably from 0.001 to 9 wt .-%, preferably from 0.01 to 8 wt .-%, further preferably from 0.5 to 7 wt .-%, in particular from 1 to 6 wt .-%, based on the total weight of the antiperspirant cosmetic agent is included. In this connection, however, it may also be provided that the fragrance in a total amount of 0.00001 to 5 wt .-%, preferably 0.001 to 4 wt .-%, preferably 0.01 to 3 wt .-%, more preferably 0 , 1 to 2 wt .-%, in particular 0.2 to 1.5 wt .-%, based on the total weight of the blowing agent-containing antiperspirant cosmetic agent is included.

• (i) Kokosfettsäureglycerinmono-, -di- und -triestern;
• (ii) Butyrospermum Parkii (Shea Butter);
• (iii) Estern von gesättigten, einwertigen C_8-18-Alkoholen mit gesättigten C_12-18-Monocarbonsäuren;
• (iv) linearen, primären C₁₂-C₂₄-Alkanolen;
• (v) Estern aus einem gesättigten, einwertigen C₁₆-C₆₀-Alkanol und einer gesättigten C₈-C₃₆-Monocarbonsäure, insbesondere Cetylbehenat, Stearylbehenat und C₂₀-C₄₀-Alkylstearat;
• (vi) Glycerintriestern von gesättigten linearen C₁₂-C₃₀-Carbonsäuren, die hydroxyliert sein können, insbesondere hydriertes Palmöl, hydriertes Kokosöl, hydriertes Rizinusöl, Glyceryltribehenat und Glyceryltri-12-hydroxystearat;
• (vii) natürlichen pflanzlichen Wachsen, insbesondere Candelillawachs, Carnaubawachs, Japanwachs, Zuckerrohrwachs, Ouricourywachs, Korkwachs, Sonnenblumenwachs, Fruchtwachse;
• (viii) tierischen Wachsen, insbesondere Bienenwachs, Schellackwachs und Walrat;
• (ix) synthetischen Wachsen, insbesondere Montanesterwachse, hydrierte Jojobawachse und Sasolwachse, Polyalkylenwachse und Polyethylenglycolwachse, C₂₀-C₄₀-Dialkylester von Dimersäuren, C_30-50-Alkylbienenwachs sowie Alkyl- und Alkylarylester von Dimerfettsäuren, Paraffinwachse; sowie
• (x) deren Mischungen.

According to another preferred embodiment of the present invention, the wax is selected from the group of

• (i) coconut fatty acid glycerol mono-, di- and triesters;
• (ii) Butyrospermum Parkii (Shea Butter);
• (iii) esters of saturated monohydric C _8-18 alcohols with saturated C _12-18 monocarboxylic acids;
• (iv) linear, primary C ₁₂ -C ₂₄ alkanols;
• (v) esters of a saturated, monohydric C ₁₆ -C ₆₀ alkanol and a saturated C ₈ -C ₃₆ monocarboxylic acid, in particular cetyl behenate, stearyl behenate and C ₂₀ -C ₄₀ alkyl stearate;
• (vi) glycerol triesters of saturated linear C ₁₂ -C ₃₀ carboxylic acids which may be hydroxylated, in particular hydrogenated palm oil, hydrogenated coconut oil, hydrogenated castor oil, glyceryl tribehenate and glyceryl tri-12-hydroxy stearate;
• (vii) natural vegetable waxes, especially candelilla wax, carnauba wax, Japan wax, sugarcane wax, ouricoury wax, cork wax, sunflower wax, fruit waxes;
• (viii) animal waxes, in particular beeswax, shellac wax and spermaceti;
• (ix) synthetic waxes, in particular montan ester waxes, hydrogenated jojoba waxes and sasol waxes, polyalkylene waxes and polyethylene glycol waxes, C ₂₀ -C ₄₀ dialkyl esters of dimer acids, C _30-50 alkyl beeswax and alkyl and alkylaryl esters of dimer fatty acids, paraffin waxes; such as
• (x) their mixtures.

Especially preferred are products sold under the INCI name Cocoglycerides, in particular the commercial products Novata ^® (ex BASF), particularly preferably Novata AB ^®, a mixture of _C12-18 mono-, di- and triglycerides, which is in the range 30-32 ° C melts, and the products of the Softisan series (Sasol Germany GmbH) with the INCI name Hydrogenated Cocoglycerides, in particular Softisan 100, 133, 134, 138, 142. Other preferred esters of saturated, monohydric C _12-18 alcohols with saturated C _12-18 monocarboxylic acids are stearyl laurate, cetearyl (z. B. Crodamol ^® CSS), cetyl palmitate (z. B. Cutina ^® CP) and myristyl myristate (z. B. Cetiol ^® MM). Furthermore, a C ₂₀ -C ₄₀ -alkyl stearate is preferably used as the wax component. This ester is known by the names Kesterwachs K82H or Kesterwachs K80H and is marketed by Koster Keunen Inc.

In the context of the present invention, it is preferred if the wax in a total amount of 0.01 to 50 wt .-%, preferably from 3 to 40 wt .-%, preferably from 5 to 30 wt .-%, in particular from 6 to 25 wt .-%, based on the total weight of the antiperspirant cosmetic agent is included.

A particularly good antiperspirant effect is obtained in the context of the present invention, if the antiperspirant aluminum salt in a total amount of 1 to 40 wt .-%, preferably from 3 to 35 wt .-%, preferably from 4 to 32 wt .-%, on preferably from 5 to 28 wt .-%, more preferably from 8 to 25 wt .-%, in particular from 12 to 22 wt .-%, based on the total weight of the antiperspirant cosmetic agent is included. However, it can also be provided that the antiperspirant aluminum salt in a total amount of 0.1 to 20 wt .-%, preferably from 0.5 to 15 wt .-%, preferably from 1 to 12 wt .-%, more preferably from 1.5 to 10 wt .-%, in particular from 2 to 8 wt .-%, based on the total weight of the blowing agent-containing antiperspirant composition is included.

• (i) wasserlöslichen adstringierenden anorganischen Salzen des Aluminiums, insbesondere Aluminiumchlorhydrat, Aluminiumsesquichlorohydrat, Aluminiumdichlorohydrat, Aluminium-hydroxid, Kaliumaluminiumsulfat, Aluminiumbromhydrat, Aluminiumchlorid, Aluminiumsulfat;
• (ii) wasserlöslichen adstringierenden organischen Salzen des Aluminiums, insbesondere Aluminiumchlorhydrex-Propylenglycol, Aluminiumchlorhydrex-Polyethylenglycol, Aluminium-Propylenglycol-Komplexe, Aluminiumsesquichlorhydrex-Propylenglycol, Aluminiumsesqui-chlorhydrex-Polyethylenglycol, Aluminium-Propylenglycol-dichlorhydrex, Aluminium-Poly-ethylenglycoldichlorhydrex, Aluminiumundecylenoylcollagenaminosäure, Natriumaluminium-lactat, Natriumaluminiumchlorhydroxylactat, Aluminium-lipoaminosäuren, Aluminiumlactat, Aluminiumchlorohydroxyallantoinat, Natrium-Aluminium-Chlorohydroxylactat;
• (iii) wasserlöslichen adstringierenden anorganischen Aluminium-Zirkonium-Salzen, insbesondere Aluminiumzirconiumtrichlorhydrat, Aluminiumzirconiumtetrachlorhydrat, Aluminiumzirconiumpentachlorhydrat, Aluminiumzirconiumoctachlorhydrat;
• (iv) wasserlöslichen adstringierenden organischen Aluminium-Zirkonium-Salzen, insbesondere Aluminiumzirkonium-Propylenglycol-Komplexe, Aluminiumzirconiumtrichlorhydrexglycin, Aluminiumzirconiumtetrachlorhydrexglycin, Aluminiumzirconiumpentachlorhydrexglycin, Aluminiumzirconiumoctachlorhydrexglycin; sowie
• (v) deren Mischungen.

In the context of the present invention, the antiperspirant aluminum salt may be selected from the group of

• (i) water-soluble astringent inorganic salts of aluminum, especially aluminum chlorohydrate, aluminum sesquichlorohydrate, aluminum dichlorohydrate, aluminum hydroxide, potassium aluminum sulfate, aluminum bromohydrate, aluminum chloride, aluminum sulfate;
• (ii) water-soluble astringent organic salts of aluminum, especially aluminum chlorohydrex-propylene glycol, aluminum chlorohydrex-polyethylene glycol, aluminum-propylene glycol complexes, aluminum sesquichlorohydrex-propylene glycol, aluminum sesqui-chlorohydrex-polyethylene glycol, aluminum-propylene glycol dichlorohydrex, aluminum-poly-ethylene glycol dichlorohydrex, aluminum undecylenoyl collagen amino acid, sodium aluminum lactate, sodium aluminum chlorhydroxactate, aluminum lipoamino acids, aluminum lactate, aluminum chlorohydroxyallantoinate, sodium aluminum chlorohydroxy lactate;
• (iii) water-soluble astringent inorganic aluminum-zirconium salts, especially aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium pentachlorohydrate, aluminum zirconium octachlorohydrate;
• (iv) water-soluble astringent organic aluminum-zirconium salts, especially aluminum zirconium-propylene glycol complexes, aluminum zirconium trichlorohydrex glycine, aluminum zirconium tetrachlorohydrex glycine, aluminum zirconium pentachlorohydrex glycine, aluminum zirconium octachlorohydrex glycine; such as
• (v) their mixtures.

The term "antiperspirant aluminum salts" are understood according to the invention no aluminosilicates and zeolites. Furthermore, according to the invention, water-soluble aluminum salts mean those salts which have a solubility of at least 3% by weight at 20 ° C., ie. H. At least 3 g of the antiperspirant aluminum salt dissolve in 97 g of water at 20 ° C.

Particularly preferred inorganic aluminum salts are selected from aluminum chlorohydrate, in particular aluminum chlorohydrate having the general formula [Al ₂ (OH) ₅ Cl. 1-6H ₂ O] _n , preferably [Al ₂ (OH) ₅ Cl. 2-3H ₂ O] _n , which may be in unactivated (polymerized) or in activated (depolymerized) form, and aluminum chlorohydrate of the general formula [Al ₂ (OH) ₄ Cl ₂ .1-6H ₂ O] _n , preferably [Al ₂ (OH) ₄ Cl ₂ 2-3H ₂ O] _n , which may be in unactivated (polymerized) or in activated (depolymerized) form. The production of such antiperspirant aluminum salts is for example in the publications US 3,887,692 A. . US 3 904 741 A . US 4,359,456 A . GB 2 048 229 A and GB 1 347 950 A disclosed.

According to the invention particularly preferred antiperspirant aluminum salts are selected from so-called "activated" aluminum salts, which are also referred to as "antiperspirant active ingredients" with enhanced activity (English: enhanced activity). Such agents are known in the art and are also commercially available. Their preparation is for example in the publications GB 2 048 229 A . US Pat. No. 4,775,528 and US 6 010 688 A disclosed. Activated aluminum salts are typically produced by heat-treating a dilute solution of the appropriate salt (eg, a 10 wt.% Salt solution) to increase its HPLC peak 4-to-peak 3 area ratio. The activated salt can then be dried to a powder, in particular spray-dried. In addition to the spray drying z. B. also suitable for drum drying. Activated aluminum salts typically have a HPLC peak 4-to-peak 3 area ratio of at least 0.4, preferably at least 0.7, especially at least 0.9, with at least 70% of the aluminum attributable to these HPLC peaks.

Also known in this connection are "activated" aluminum zirconium salts which have a high HPLC peak 5 aluminum content, in particular a peak 5 area of at least 33%, preferably of at least 45%, based on the total area under the peaks 2 to 5, measured by HPLC of a 10% by weight aqueous solution of the active ingredient under conditions in which the aluminum species are resolved into at least 4 consecutive peaks (designated peaks 2 to 5). Preferred aluminum-zirconium salts having a high HPLC peak 5-aluminum content (also referred to as "E ⁵ AZCH") are disclosed, for example, in the references US Pat. No. 6,436,381 A and US 6 649 152 A disclosed. Furthermore, the abovementioned activated aluminum-zirconium salt may additionally be stabilized with a water-soluble strontium salt and / or with a water-soluble calcium salt, as described, for example, in the document US Pat. No. 6,923,952 A are disclosed.

It is also possible according to the invention, antiperspirant aluminum salts as nonaqueous solutions or solubilized an activated antiperspirant aluminum or aluminum zirconium salt, for example according to the document US 6 010 688 A to use. Such aluminum or aluminum zirconium salts are stabilized by the addition of an effective amount of a polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups, preferably propylene glycol, sorbitol and pentaerythritol, against the loss of activation of the salt.

Also particularly preferred are complexes of activated aluminum or aluminum-zirconium antiperspirant salts with a polyhydric alcohol containing from 20 to 50% by weight, preferably from 20 to 42% by weight, activated antiperspirant aluminum or aluminum zirconium salt and from 2 to 16 Wt .-% molecularly bound water, the remainder to 100 wt .-% is at least one polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups. Propylene glycol, propylene glycol / sorbitol mixtures and propylene glycol / pentaerythritol mixtures are preferred such alcohols. Such inventively preferred complexes of an activated antiperspirant aluminum or aluminum zirconium salt with a polyhydric alcohol are, for. B. in the publications US 5 643 558 A and US Pat. No. 6,245,325 disclosed.

In the context of the present invention, it is also possible, as antiperspirant aluminum salts of basic calcium aluminum salts, as z. B. in the document US 2 571 030 A are disclosed use. These salts can be obtained by reacting calcium carbonate with aluminum chlorhydroxide or aluminum chloride and aluminum powder or by adding calcium chloride dihydrate to aluminum chlorhydroxide. However, it is also possible to aluminum-zirconium complexes, which are buffered with salts of amino acids, in particular with alkali and Erdalkaliglycinaten, and as such. B. in the document US 4 017 599 A are disclosed use.

As inventively preferred antiperspirant activated aluminum and aluminum zirconium salts can also in the following references US Pat. No. 6,245,325 . US 6 042 816 A . US Pat. No. 6,245,325 . US 6 042 816 A . US Pat. No. 6,245,325 . US 6 042 816 A . US Pat. No. 6,245,325 . US 6 042 816 A or US Pat. No. 7,105,691 A. cited aluminum or aluminum-zirconium salts are used, which are preferably stabilized by amino acids, in particular glycine, hydroxyalkanoic acids, in particular glycolic acid and lactic acid, or betaines.

Further preferred activated aluminum salts are those of the general formula Al ₂ (OH) _6-a Xa, wherein X is Cl, Br, I or NO ₃ and "a" is a number from 0.3 to 5, preferably from 0.8 to 2.5 is in particular from 1 to 2, so that the molar ratio of Al: X is 0.9: 1 to 2.1: 1. Such activated antiperspirant aluminum salts are for example in the document US Pat. No. 6,074,632 A disclosed. Particularly preferred is aluminum chlorohydrate (ie X in the above formula is Cl) and especially 5/6 basic aluminum chlorohydrate with "a" = 1 such that the molar ratio of aluminum to chlorine is 1.9: 1 to 2.1: 1 ,

Preferred activated aluminum-zirconium salts are those of the general formula ZrO (OH) _{2 -pb} Y _b , wherein Y is Cl, Br, I, NO ₃ or SO ₄ , b is a rational number of 0.8 to 2 and p is the Valency of Y is such that the Al: Zr molar ratio is from 2 to 10 and the metal: (X + Y) ratio is from 0.73 to 2.1, preferably from 0.9 to 1.5. Such activated antiperspirant aluminum-zirconium salts are, for example, in the aforementioned document US Pat. No. 6,074,632 A disclosed. A particularly preferred salt is aluminum-zirconium chlorohydrate (ie, X and Y represent CI), which has an Al: Zr ratio of 2 to 10 and a molar metal: Cl ratio of 0.9 to 2.1. Preferred antiperspirant active ingredients are in the publications US 6,663,854 A and US 2004/0009133 A1 disclosed.

Particularly preferred antiperspirant aluminum salts according to the invention have a molar metal-to-chloride ratio of 1.9 to 2.1. The metal-to-chloride ratio of aluminum sesquichlorohydrates, which is also particularly preferred in the invention, is 1.5: 1 to 1.8: 1. Preferred aluminum zirconium tetrachlorohydrates have a molar ratio of Al: Zr of 2 to 6 and of metal: chloride of 0.9 to 1.3, in particular salts having a molar metal to chloride ratio of 0.9 to 1.1, preferably from 0.9 to 1.0 are preferred.

In the present invention, a particularly effective hydrogel formation between lysozyme and / or bovine serum albumin (BSA) and / or yogurt protein and the antiperspirant aluminum salt is achieved when lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein in a Total amount of 0.05 to 15 wt .-%, preferably from 0.1 to 10 wt .-%, preferably from 0.3 to 5 wt .-%, more preferably from 0.5 to 7 wt .-%, still more preferably from 0.8 to 5 wt .-%, in particular from 1 to 3 wt .-%, based on the total weight of the antiperspirant cosmetic agent is included. However, it can also be provided in the context of the invention that the antiperspirant cosmetic agents lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein in a total amount of 0.05 to 35 wt .-%, preferably 0.3 to 30 wt .-%, preferably 0.5 to 25 wt .-%, more preferably from 0.7 to 15 wt .-%, even more preferably from 1.0 to 12 wt .-%, in particular from 1.5 to 10 wt .-%, based on the total weight of the blowing agent-containing antiperspirant cosmetic agent. Without wishing to be limited to this theory, the use of the abovementioned amount (s) of lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein results in a significantly increased and extremely high yield pH-selective hydrogel formation with the antiperspirant aluminum salt. In this way, an effective blockage of the excretory ducts of the sweat glands and thus an excellent antiperspirant effect is ensured. Furthermore, the use of the aforementioned amount (s) of lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein does not result in undesirable premature hydrogel formation in the antiperspirant cosmetic composition or on the skin surface, so that the excellent antiperspirant effect itself is ensured over long storage periods

The antiperspirant effect of the antiperspirant cosmetic agents of the present invention can be further improved if the antiperspirant cosmetic agent has a weight ratio of the antiperspirant aluminum salt to lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein of 40: 1 to 19: 1, preferably 30 From 1 to 16: 1, preferably from 20: 1 to 15: 1, more preferably from 10: 1 to 13: 1, even more preferably from 9: 1 to 12: 1, in particular from 8: 1 to 1: 1, having. In this connection it can also be provided that the antiperspirant cosmetic agent has a weight ratio of the antiperspirant aluminum salt to lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein of 1: 1.5 to 1:50, preferably 1: 2 to 1:35, more preferably from 1: 2.5 to 1:30, even more preferably from 1: 3 to 1:25, in particular from 1: 3.5 to 1:20. The above-mentioned weight ratio refers to the total amount of all antiperspirant aluminum salts and the total amount of lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein in the antiperspirant cosmetic agent.

In a particularly preferred embodiment, the weight ratio of the antiperspirant aluminum salt to lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein is 1.5: 1. In addition, the use of a weight ratio of the antiperspirant aluminum salt to lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein of 10: 1 to antiperspirant cosmetic agents according to the invention, which have an excellent antiperspirant effect and even after long storage periods, no significant deterioration the antiperspirant effect occurs. Furthermore, when using the weight ratio mentioned above, protic solvents, in particular in high concentrations or amounts, can be used without the antiperspirant effect of the antiperspirant cosmetic agents according to the invention being adversely affected, so that an extremely flexible formulation of the compositions according to the invention is possible.

According to another embodiment of the present invention, the antiperspirant cosmetic agent contains no zirconium-containing compounds. The inventive avoidance of the use of zirconium-containing antiperspirant compounds, such as zirconium-aluminum mixed salts results in the cost-effective provision of the antiperspirant cosmetic agents of the invention, since the raw materials for the production of zirconium-containing compounds have higher prices.

The antiperspirant cosmetic agent preferably contains free water in a total amount of less than 10% by weight, preferably less than 8% by weight, preferably less than 5% by weight, more preferably less than 3% by weight. even more preferably less than 1% by weight, in particular 0% by weight, based on the total weight of the antiperspirant cosmetic agent. For the purposes of the present invention, free water is thus understood to mean water which is different from water of crystallization, water of hydration or similar molecularly bound water of the constituents used, in particular the antiperspirant aluminum salts.

Surprisingly, it has been found that the blockage of the excretory ducts of the sweat glands can be significantly increased by a hydrogel formation which occurs when at least one antiperspirant aluminum salt is combined with lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein, if the antiperspirant cosmetic according to the invention Agent free water in an amount of 15 to 96 wt .-%, based on the total weight of the antiperspirant cosmetic agent included. In a particularly preferred embodiment of the present invention, the antiperspirant cosmetic agent therefore contains free water in a total amount of 15 to 96 wt .-%, preferably from 25 to 80 wt .-%, preferably from 30 to 70 wt .-%, in particular of 40 to 60 wt .-%, based on the total weight of the antiperspirant cosmetic agent.

The antiperspirant cosmetic agents according to the invention are preferably in the form of a suspension of the undissolved antiperspirant aluminum salt in the cosmetic oil which is liquid at 20 ° C. and 1013 hPa.

In a further preferred dosage form, the antiperspirant cosmetic agent is present as a water-in-oil emulsion. This may in particular be a sprayable water-in-oil emulsion which can be sprayed by means of a propellant. In this context, it is preferred if the present invention in the form of a water-in-oil emulsion antiperspirant cosmetic agent lysozyme and / or bovine serum albumin (BSA) and / or yogurt protein in a total amount of 0.05 to 20 wt. -%, preferably from 0.1 to 15 wt .-%, preferably from 0.3 to 10 wt .-%, more preferably from 0.5 to 7 wt .-%, still more preferably from 0.8 to 5 wt .-%, in particular from 1 to 3 wt .-%, based on the total weight of the antiperspirant cosmetic agent contains.

In the context of the present invention, it can also be provided that the antiperspirant cosmetic agent is present as an oil-in-water emulsion. In this case, the agent according to the invention is preferably sprayed as a propellant-free pump spray or squish spray or applied as a roll-on. In this connection, it is preferred if the antiperspirant cosmetic agent in the form of an oil-in-water emulsion comprises lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein in a total amount of 0.05 to 20% by weight. %, preferably from 0.1 to 15 wt .-%, preferably from 0.3 to 10 wt .-%, more preferably from 0.5 to 7 wt .-%, still more preferably from 0.8 to 5 wt. %, in particular from 1 to 3 wt .-%, based on the total weight of the antiperspirant cosmetic agent contains.

According to the invention, it may further be provided that the antiperspirant cosmetic agent is present as an aqueous, aqueous-alcoholic or aqueous-glycolic solution. Owing to the combination according to the invention of an antiperspirant aluminum salt with lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein, even protic solvents, such as aqueous solutions, can be used to formulate the antiperspirant cosmetic agents according to the invention without a significant reduction in antiperspirant activity , The addition of lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein ensures effective closure of the excretory ducts of the sweat glands, even when protic solvents are used, and thus provides excellent antiperspirant activity.

According to a preferred embodiment of the present invention, the antiperspirant cosmetic agent contains ethanol in a total amount of 1 to 90 wt .-%, preferably from 5 to 70 wt .-%, preferably from 7 to 50 wt .-%, in particular from 10 to 30 Wt .-%, based on the total weight of the antiperspirant cosmetic agent. However, it can also be provided that the antiperspirant cosmetic agent ethanol in a total amount of 10 to 95 wt .-%, preferably from 15 to 90 wt .-%, preferably from 20 to 87 wt .-%, more preferably from 30 to 85 wt .-%, in particular from 40 to 80 wt .-%, based on the total weight of the antiperspirant cosmetic agent contains. As stated above, the use of lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein may even use high levels of protic solvents, such as ethanol, without adversely affecting the antiperspirant activity of the antiperspirant cosmetic of the present invention.

The application of the antiperspirant cosmetic agent according to the invention can be carried out by means of various methods. According to a preferred embodiment, the antiperspirant cosmetic agent is formulated as a spray application. The spray application is carried out with a spray device which contains a filling of the liquid, viscous-flowable, suspension-shaped or powdered antiperspirant cosmetic agent according to the invention in a container. The filling may be under the pressure of a propellant (compressed gas cans, compressed gas packages, aerosol dispensers), or it may be a mechanically operated pump sprayer without propellant (pump sprays / squeeze bottle). The containers have a removal device, preferably in the form of valves, which allow the removal of the contents as a mist, smoke, foam, powder, paste or liquid jet. Cylindrical vessels made of metal (aluminum, tinplate, volume preferably not more than 1,000 ml), protected or non-splitting glass or plastic (preferably a maximum of 220 ml) or splintering glass or plastic (volume preferably 50 to 400) are used as containers for the spraying devices ml) in question. Cream, gel, pasty and liquid agents may e.g. be packaged in pump, spray or squeeze dispensers, especially in multi-chamber pump, multi-chamber spray or multi-chamber squeeze dispensers. The packaging for the compositions according to the invention may be opaque, but also transparent or translucent.

The antiperspirant cosmetic is preferably formulated as a stick, soft solid, cream, roll-on, dibenzylidenalditol-based gel, loose or compact powder. The formulation of the antiperspirant cosmetic agents of the invention in a particular dosage form, such as an antiperspirant roll-on, an antiperspirant stick or an antiperspirant gel, is preferably based on the requirements of the intended use. Depending on the intended use, the antiperspirant cosmetic agents according to the invention can therefore be present in solid, semisolid, liquid, disperse, emulsified, suspended, gelatinous, multiphase or powdery form. For the purposes of the present invention, the term liquid also includes any types of solid dispersions in liquids. In the context of the present invention, multiphase antiperspirant cosmetic agents according to the invention are also understood to mean agents which have at least two different phases with a phase separation and in which the phases can be arranged horizontally, ie one above the other, or vertically, ie side by side.

The application can be done, for example, with a roller ball applicator. Such rollers have a ball mounted in a ball bed, which can be moved by movement over a surface. In this case, the ball absorbs some of the antiperspirant cosmetic agent according to the invention to be distributed and conveys it to the surface to be treated. The packaging for the compositions according to the invention can, as stated above, be opaque, transparent or translucent.

Furthermore, it is also possible to apply the antiperspirant cosmetic agents according to the invention by means of a solid stick in the form of a solid emulsion.

However, it may also be preferred according to the invention that the antiperspirant cosmetic agent is contained on and / or in a disposable substrate selected from the group of wipes, pads and bulbs. Especially preferred are wet wipes, i. prefabricated for the user, preferably individually packaged, wet wipes, such as. B. from the field of glass cleaning or from the field of wet toilet paper are well known. Such wet wipes, which can advantageously also contain preservatives, are impregnated or applied with an antiperspirant cosmetic agent according to the invention and preferably individually packaged. You can z. B. be used as a deodorant cloth, which is particularly interesting for use on the go. Preferred substrate materials are selected from porous sheet-like cloths. They can be made of a fibrous or cellular flexible material which has sufficient mechanical stability and softness for application to the skin. These wipes include wipes of woven and nonwoven synthetic and natural fibers, felt, paper or foam, such as hydrophilic polyurethane foam. Deodorizing or antiperspirant substrates which are preferred according to the invention can be obtained by impregnation or impregnation or else by melting a perspiration-inhibiting cosmetic agent according to the invention onto a substrate.

The antiperspirant cosmetic agents of the present invention may further contain other adjuvants. The antiperspirant cosmetic agents according to the invention preferably contain at least one wide adjuvant selected from the group of (i) emulsifiers and / or surfactants; (ii) hydrogel formers; (iii) chelating agents; (iv) deodorant agents; (v) monohydric and / or polyhydric alcohols and / or polyethylene glycols; (vi) skin-cooling agents; (vii) propellants; (viii) thickeners and (ix) their mixtures.

Emulsifiers and surfactants which are preferably suitable according to the invention are selected from anionic, cationic, nonionic, amphoteric, in particular ampholytic and zwitterionic emulsifiers and surfactants. Surfactants are amphiphilic (bifunctional) compounds which consist of at least one hydrophobic and at least one hydrophilic moiety. The hydrophobic moiety is preferably a hydrocarbon chain of 8 to 28 carbon atoms, which may be saturated or unsaturated, linear or branched. Particularly preferably, this C ₈ -C ₂₈ -alkyl chain is linear.

By anionic surfactants are meant surfactants with exclusively anionic charges; they contain z. As carboxyl groups, sulfonic acid groups or sulfate groups. Particularly preferred anionic surfactants are alkyl sulfates, alkyl ether sulfates, acyl glutamates and C _8-24 carboxylic acids and their salts, the so-called soaps.

Cationic surfactants are understood as meaning surfactants with exclusively cationic charges; they contain z. B. quaternary ammonium groups. Preference is given to cationic surfactants of the quaternary ammonium compounds, esterquats and amidoamines type. Preferred quaternary ammonium compounds are ammonium halides and the imidazolium compounds known under the INCI names Quaternium-27 and Quaternium-83. Further cationic surfactants which can be used according to the invention are the quaternized protein hydrolysates. Preferred ester quats are quaternized ester salts of fatty acids Triethanolamine, quaternized ester salts of fatty acids with diethanolalkylamines and quaternized ester salts of fatty acids with 1,2-dihydroxypropyldialkylamines. The amphoteric surfactants are subdivided into ampholytic surfactants and zwitterionic surfactants. Ampholytic surfactants are understood as meaning those surface-active compounds which have both acidic (for example -COOH or -SO ₃ H groups) and basic hydrophilic groups (for example amino groups) and thus behave acidic or basic depending on the condition. Zwitterionic surfactants are understood by the person skilled in the art to be surfactants which carry both a negative and a positive charge in the same molecule. Examples of preferred zwitterionic surfactants are the betaines, the N-alkyl-N, N-dimethylammonium glycinates, the N-acyl-aminopropyl-N, N-dimethylammoniumglycinate and the 2-alkyl-3-carboxymethyl-3-hydroxyethyl-imidazoline with each 8 to 24 carbon atoms in the alkyl group. Examples of preferred ampholytic surfactants are N-alkylglycines, N-alkylaminopropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropyl-glycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having 8 to 24 Carbon atoms in the alkyl group

The compositions according to the invention, which are formulated as an emulsion, in particular as an oil-in-water emulsion, preferably contain at least one nonionic oil-in-water emulsifier having an HLB value of more than 7 to 20. These are emulsifiers which are generally known to the person skilled in the art, as are described, for example, in US Pat Kirk-Othmer, "Encyclopedia of Chemical Technology", 3rd ed., 1979, Vol. 8, pp. 913-916 , are listed. For ethoxylated products, the HLB value is calculated according to the formula HLB = (100-L): 5, where L is the weight fraction of the lipophilic groups, that is the fatty alkyl or fatty acyl groups, in the ethylene oxide adducts, expressed in weight percent. In this connection, it may be preferred according to the invention if, furthermore, a water-in-oil emulsifier having an HLB value of greater than 1.0 and less than or equal to 7.0 is used. In the context of the present invention, suitable nonionic oil-in-water emulsifiers and suitable nonionic water-in-oil emulsifiers are described, for example, in the German Offenlegungsschrift DE 10 2006 004 957 A1 described.

For thickening of the antiperspirant cosmetic agents according to the invention preferably hydrogel-forming substances are used which are selected from cellulose ethers, especially hydroxyalkylcelluloses, in particular hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxyethylcellulose, carboxymethylcellulose, cetylhydroxyethylcellulose, hydroxybutylmethylcellulose, methylhydroxyethylcellulose, furthermore xanthan gum, sclerotium gum, succinoglucans, polygalactomannans , in particular guar gums and locust bean gum, in particular guar gum and locust bean gum itself and the nonionic hydroxyalkyl guar derivatives and locust bean gum derivatives such as hydroxypropyl guar, carboxymethylhydroxypropyl guar, hydroxypropylmethyl guar, hydroxyethyl guar and carboxymethyl guar, furthermore pectins, agar, carrageenan (carrageenan ), Tragacanth, gum arabic, karaya gum, tara gum, gellan, gelatin, casein, propylene glycol alginate, alginic acids and their salts, esp Sodium alginate, potassium alginate and calcium alginate, further polyvinylpyrrolidones, polyvinyl alcohols, polyacrylamides, further - albeit less preferred - physically (eg. B. by Vorverkleisterung) and / or chemically modified starches, especially hydroxypropylated starch phosphates and Octenylstärkesuccinaten and their aluminum, calcium or sodium salts, furthermore - also less preferred - acrylic acid-acrylate copolymers, acrylic acid-acrylamide copolymers, acrylic acid-vinylpyrrolidone copolymers , Acrylic acid-vinylformamide copolymers and polyacrylates. Particularly preferred hydrogel formers are selected from cellulose ethers, especially from hydroxyalkylcelluloses, in particular from hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxyethylcellulose, carboxymethylcellulose, cetylhydroxyethylcellulose, hydroxybutylmethylcellulose and methylhydroxyethylcellulose, and mixtures thereof. Hydroxyethyl cellulose is preferably used as hydrogel former.

In order to further support the blockage of the excretory ducts of the sweat glands by hydrogel formation with the addition of lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein, it may be advantageous for the antiperspirant cosmetic agents according to the invention to comprise at least one chelating agent selected of ethylenediaminetetraacetic acid (EDTA) and its salts, and of nitrilotriacetic acid (NTA) and mixtures of these substances, in a total amount of from 0.01 to 0.5% by weight, preferably from 0.02 to 0.3% by weight, in particular from 0.05 to 0.1% by weight, based on the total weight of the antiperspirant agent according to the invention.

The antiperspirant effect of the antiperspirant cosmetic agents according to the invention can be further increased if at least one deodorant active ingredient in a total amount of 0.0001 to 40 wt .-%, preferably from 0.2 to 20 wt .-%, preferably from 1 to 15 wt .-%, in particular from 1.5 to 5 wt .-%, based on the total weight of the antiperspirant cosmetic agent according to the invention, is included. If ethanol is used in the inventive compositions, this applies in the Not within the scope of the present invention as a deodorant active ingredient, but as a component of the carrier. Deodorant agents which are preferred according to the invention are selected from the group of (i) silver salts; (ii) aromatic alcohols, in particular 2-benzylheptan-1-ol and mixtures of 2-benzylheptan-1-ol and phenoxyethanol; (iii) 1,2-alkanediols having 5 to 12 carbon atoms, especially 3- (2-ethylhexyloxy) -1,2-propanediol; (iv) triethyl citrate; (v) agents against exoesterases, especially against arylsulfatase, lipase, beta-glucuronidase and cystathion-beta-lyase; (vi) cationic phospholipids; (vii) odor absorbers, in particular silicates, such as montmorillonite, kaolinite, ilit, beidellite, nontronite, saponite, hectorite, bentonite, smectite and talc, zeolites, zinc ricinoleate, cyclodextrins; (viii) deodorizing ion exchanger; (ix) antimicrobial agents; (x) prebiotic active components; and (xi) mixtures of these deodorant agents.

Preferred antiperspirant cosmetic agents according to the invention also contain at least one water-soluble polyhydric C _2-9 -alkanol having 2 to 6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3 to 50 ethylene oxide units and mixtures thereof. This does not include the abovementioned deodorant active ingredients in the form of 1,2-alkanediols. Preferred alkanols are selected from 1,2-propylene glycol, 2-methyl-1,3-propanediol, glycerol, 1,2-butylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, pentylene glycols such as 1,2-pentanediol and 1 , 5-pentanediol, hexanediols such as 1,2-hexanediol and 1,6-hexanediol, hexanetriols such as 1,2,6-hexanetriol, 1,2-octanediol, 1,8-octanediol, dipropylene glycol, tripropylene glycol, diglycerol, triglycerol, erythritol , Sorbitol, cis-1,4-dimethylolcyclohexane, trans-1,4-dimethylolcyclohexane, any mixtures of isomers of cis and trans-1,4-dimethylolcyclohexane, and mixtures of the abovementioned substances. Suitable water-soluble polyethylene glycols are selected from PEG-3, PEG-4, PEG-6, PEG-7, PEG-8, PEG-9, PEG-10, PEG-12, PEG-14, PEG-16, PEG-18 and PEG-20 and mixtures thereof, with PEG-3 to PEG-8 being preferred.

According to another embodiment of the present invention, the antiperspirant cosmetic agents further contain at least one skin-cooling agent. Skin-cooling active ingredients suitable according to the invention are, for example, menthol, isopulegol and menthol derivatives, eg. Menthyl lactate, menthyl glycolate, menthyl ethyl oxamate, menthyl pyrrolidone carboxylic acid, menthyl methyl ether, menthoxypropanediol, menthone glycerol acetal (9-methyl-6- (1-methylethyl) -1,4-dioxaspiro (4.5) decane-2-methanol), monomethyl succinate, 2-hydroxymethyl -3,5,5-trimethylcyclohexanol and 5-methyl-2- (1-methylethyl) cyclohexyl-N-ethyloxamate. Preferred skin-cooling active ingredients are menthol, isopulegol, menthyl lactate, menthoxypropanediol, menthylpyrrolidonecarboxylic acid and 5-methyl-2- (1-methylethyl) cyclohexyl-N-ethyloxamate, as well as mixtures of these substances, in particular mixtures of menthol and menthyl lactate, menthol, menthol glycolate and menthyl lactate, menthol and menthoxypropanediol or menthol and isopulegol.

Furthermore, it can be provided that the antiperspirant cosmetic agents according to the invention contain a propellant. In this case, they are formulated as a propellant-driven aerosol.

Preferred propellants (propellants) are propane, propene, n-butane, isobutane, isobutene, n-pentane, pentene, isopentane, isopentene, methane, ethane, dimethyl ether, nitrogen, air, oxygen, nitrous oxide, 1,1,1,3-tetrafluoroethane, heptafluoro-n-propane, perfluoroethane, monochlorodifluoromethane, 1,1-difluoroethane, tetrafluoropropenes, both individually and in their mixtures. Also hydrophilic propellants, such. As carbon dioxide, can be used advantageously in the context of the present invention, when the proportion of hydrophilic gases is selected low and lipophilic propellant gas (eg., Propane / butane) is present in excess. Particularly preferred are propane, n-butane, isobutane and mixtures of these propellants. It has been found that the use of n-butane as the only propellant gas according to the invention can be particularly preferred. The total amount of the blowing agent is 20 to 95 wt.%, Preferably 30 to 85 wt.%, In particular 40 to 75 wt .-%, each based on the total weight of the antiperspirant, consisting of the inventive antiperspirant cosmetic agent, the blowing agent and optionally further excipients.

As excipients, lipophilic thickeners can furthermore be used according to the invention. Preferably, the at least one antiperspirant aluminum salt is suspended undissolved in at least one at 20 ° C and 1013 hPa liquid cosmetic oil. For better usability, at least one lipophilic thickener may be added to this suspension as a suspending aid. Lipophilic thickeners preferred according to the invention are selected from hydrophobized clay minerals and fumed silicic acids.

• – mindestens ein schweißhemmendes Aluminiumsalz in einer Gesamtmenge von 2 bis 75 Gew.-%, vorzugsweise 3 bis 70 Gew.-%, bevorzugt 4 bis 65 Gew.-%, weiter bevorzugt 5 bis 55 Gew.-%, noch mehr bevorzugt 8 bis 40 Gew.-%, insbesondere 10 bis 30 Gew.-%,
• – Lysozym und/oder Bovine serum albumin (BSA) und/oder Yoghurt Protein in einer Gesamtmenge von insgesamt 0,05 bis 20 Gew.-%, vorzugsweise 0,1 bis 15 Gew.-%, bevorzugt 0,3 bis 10 Gew.-%, weiter bevorzugt 0,5 bis 7 Gew.-%, noch weiter bevorzugt 0,8 bis 5 Gew.-%, insbesondere 1 bis 3 Gew.-%,
• – 12 bis 90 Gew.-%, vorzugsweise 25 bis 55 Gew.-%, bevorzugt 30 bis 50 Gew.-%, insbesondere 35 bis 45 Gew.-% Wasser,
• – mindestens einen Emulgator und
• – mindestens einen Stoff, ausgewählt aus der Gruppe von kosmetischen Ölen, welche bei 20 °C und 1.013 hPa flüssig sind, Riechstoffen und Wachsen

enthalten. In a preferred embodiment, the antiperspirant cosmetic agents according to the invention are characterized in that they are formulated as a water-in-oil emulsion and, based on the total weight of the antiperspirant cosmetic agent according to the invention,

• - At least one antiperspirant aluminum salt in a total amount of 2 to 75 wt .-%, preferably 3 to 70 wt .-%, preferably 4 to 65 wt .-%, more preferably 5 to 55 wt .-%, still more preferably 8 bis 40% by weight, in particular 10 to 30% by weight,
• Lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein in a total amount of 0.05 to 20 wt.%, Preferably 0.1 to 15 wt.%, Preferably 0.3 to 10 wt. -%, more preferably 0.5 to 7 wt .-%, even more preferably 0.8 to 5 wt .-%, in particular 1 to 3 wt .-%,
• From 12 to 90% by weight, preferably from 25 to 55% by weight, preferably from 30 to 50% by weight, in particular from 35 to 45% by weight, of water,
• - At least one emulsifier and
• At least one substance selected from the group of cosmetic oils which are liquid at 20 ° C and 1013 hPa, fragrances and waxes

contain.

• – mindestens ein schweißhemmendes Aluminiumsalz in einer Gesamtmenge von 2 bis 75 Gew.-%, vorzugsweise 3 bis 70 Gew.-%, bevorzugt 4 bis 65 Gew.-%, weiter bevorzugt 5 bis 55 Gew.-%, noch mehr bevorzugt 8 bis 40 Gew.-%, insbesondere 10 bis 30 Gew.-%,
• – Lysozym und/oder Bovine serum albumin (BSA) und/oder Yoghurt Protein in einer Gesamtmenge von insgesamt 0,05 bis 20 Gew.-%, vorzugsweise 0,1 bis 15 Gew.-%, bevorzugt 0,3 bis 10 Gew.-%, weiter bevorzugt 0,5 bis 7 Gew.-%, noch weiter bevorzugt 0,8 bis 5 Gew.-%, insbesondere 1 bis 3 Gew.-%,
• – 15 bis 90 Gew.-%, vorzugsweise 25 bis 55 Gew.-%, bevorzugt 30 bis 50 Gew.-%, insbesondere 35 bis 45 Gew.-% Wasser,
• – mindestens einen Emulgator und
• – mindestens einen Stoff, ausgewählt aus der Gruppe von kosmetischen Ölen, welche bei 20 °C und 1.013 hPa flüssig sind, Riechstoffen und Wachsen

enthalten. In a further preferred embodiment, the antiperspirant cosmetic agents according to the invention are characterized in that they are formulated as an oil-in-water emulsion and, based on the total weight of the antiperspirant cosmetic agent according to the invention,

• - At least one antiperspirant aluminum salt in a total amount of 2 to 75 wt .-%, preferably 3 to 70 wt .-%, preferably 4 to 65 wt .-%, more preferably 5 to 55 wt .-%, still more preferably 8 bis 40% by weight, in particular 10 to 30% by weight,
• Lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein in a total amount of 0.05 to 20 wt.%, Preferably 0.1 to 15 wt.%, Preferably 0.3 to 10 wt. -%, more preferably 0.5 to 7 wt .-%, even more preferably 0.8 to 5 wt .-%, in particular 1 to 3 wt .-%,
• From 15 to 90% by weight, preferably from 25 to 55% by weight, preferably from 30 to 50% by weight, in particular from 35 to 45% by weight, of water,
• - At least one emulsifier and
• At least one substance selected from the group of cosmetic oils which are liquid at 20 ° C and 1013 hPa, fragrances and waxes

contain.

• – mindestens ein schweißhemmendes Aluminiumsalz in einer Gesamtmenge von 2 bis 75 Gew.-%, vorzugsweise 3 bis 70 Gew.-%, bevorzugt 4 bis 65 Gew.-%, weiter bevorzugt 5 bis 55 Gew.-%, noch mehr bevorzugt 8 bis 40 Gew.-%, insbesondere 10 bis 30 Gew.-%,
• – Lysozym und/oder Bovine serum albumin (BSA) und/oder Yoghurt Protein in einer Gesamtmenge von insgesamt 0,05 bis 20 Gew.-%, vorzugsweise 0,1 bis 15 Gew.-%, bevorzugt 0,3 bis 10 Gew.-%, weiter bevorzugt 0,5 bis 7 Gew.-%, noch weiter bevorzugt 0,8 bis 5 Gew.-%, insbesondere 1 bis 3 Gew.-%,
• – 15 bis 90 Gew.-%, vorzugsweise 25 bis 80 Gew.-%, bevorzugt 30 bis 75 Gew.-%, insbesondere 40 bis 60 Gew.-% Wasser, und
• – 0,01 bis 2 Gew.-%, vorzugsweise 0,1 bis 1 Gew.-%, bevorzugt 0,2 bis 0,7 Gew.-%, insbesondere 0,3 bis 0,5 Gew.-% einer ein Hydrogel bildenden Substanz

enthalten. A further preferred embodiment of the present invention comprises antiperspirant cosmetic agents according to the invention, which are characterized in that they contain, based on the total weight of the antiperspirant cosmetic agent according to the invention,

• - At least one antiperspirant aluminum salt in a total amount of 2 to 75 wt .-%, preferably 3 to 70 wt .-%, preferably 4 to 65 wt .-%, more preferably 5 to 55 wt .-%, still more preferably 8 bis 40% by weight, in particular 10 to 30% by weight,
• Lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein in a total amount of 0.05 to 20 wt.%, Preferably 0.1 to 15 wt.%, Preferably 0.3 to 10 wt. -%, more preferably 0.5 to 7 wt .-%, even more preferably 0.8 to 5 wt .-%, in particular 1 to 3 wt .-%,
• From 15 to 90% by weight, preferably from 25 to 80% by weight, preferably from 30 to 75% by weight, in particular from 40 to 60% by weight, of water, and
• - 0.01 to 2 wt .-%, preferably 0.1 to 1 wt .-%, preferably 0.2 to 0.7 wt .-%, in particular 0.3 to 0.5 wt .-% of a hydrogel forming substance

contain.

• – mindestens ein schweißhemmendes Aluminiumsalz in einer Gesamtmenge von 2 bis 75 Gew.-%, vorzugsweise 3 bis 70 Gew.-%, bevorzugt 4 bis 65 Gew.-%, weiter bevorzugt 5 bis 55 Gew.-%, noch mehr bevorzugt 8 bis 40 Gew.-%, insbesondere 10 bis 30 Gew.-%,
• – Lysozym und/oder Bovine serum albumin (BSA) und/oder Yoghurt Protein in einer Gesamtmenge von insgesamt 0,05 bis 20 Gew.-%, vorzugsweise 0,1 bis 15 Gew.-%, bevorzugt 0,3 bis 10 Gew.-%, weiter bevorzugt 0,5 bis 7 Gew.-%, noch weiter bevorzugt 0,8 bis 5 Gew.-%, insbesondere 1 bis 3 Gew.-%,
• – 15 bis 90 Gew.-%, vorzugsweise 25 bis 80 Gew.-%, bevorzugt 30 bis 75 Gew.-%, insbesondere 40 bis 60 Gew.-% Wasser, und
• – 0,01 bis 2 Gew.-%, vorzugsweise 0,1 bis 1 Gew.-%, bevorzugt 0,2 bis 0,7 Gew.-%, insbesondere 0,3 bis 0,5 Gew.-% einer ein Hydrogel bildenden Substanz

enthalten, wobei die erfindungsgemäßen schweißhemmenden kosmetischen Mittel eine dynamische Viskosität im Bereich von 10 bis 5000 mPas, vorzugsweise von 100 bis 1000 mPas, bevorzugt von 200 bis 800 mPas, gemessen mit einem Brookfield-Viskosimeter, Spindel RV 4, 20 s^–1, ohne Helipath, bei 20 °C Umgebungstemperatur und 20 °C Probentemperatur, aufweisen. A further preferred embodiment of the present invention comprises antiperspirant cosmetic agents according to the invention, which are characterized in that they contain, based on the total weight of the antiperspirant cosmetic agent according to the invention,

• - At least one antiperspirant aluminum salt in a total amount of 2 to 75 wt .-%, preferably 3 to 70 wt .-%, preferably 4 to 65 wt .-%, more preferably 5 to 55 wt .-%, still more preferably 8 bis 40% by weight, in particular 10 to 30% by weight,
• Lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein in a total amount of 0.05 to 20 wt.%, Preferably 0.1 to 15 wt.%, Preferably 0.3 to 10 wt. -%, more preferably 0.5 to 7 wt .-%, even more preferably 0.8 to 5 wt .-%, in particular 1 to 3 wt .-%,
• From 15 to 90% by weight, preferably from 25 to 80% by weight, preferably from 30 to 75% by weight, in particular from 40 to 60% by weight, of water, and
• - 0.01 to 2 wt .-%, preferably 0.1 to 1 wt .-%, preferably 0.2 to 0.7 wt .-%, in particular 0.3 to 0.5 wt .-% of a hydrogel forming substance

wherein the antiperspirant cosmetic agents according to the invention have a dynamic viscosity in the range from 10 to 5000 mPas, preferably from 100 to 1000 mPas, preferably from 200 to 800 mPas, measured with a Brookfield viscometer, spindle RV 4, 20 s ^-1 , without Helipath, at 20 ° C ambient temperature and 20 ° C sample temperature exhibit.

• – mindestens ein schweißhemmendes Aluminiumsalz in einer Gesamtmenge von 2 bis 75 Gew.-%, vorzugsweise 3 bis 70 Gew.-%, bevorzugt 4 bis 65 Gew.-%, weiter bevorzugt 5 bis 55 Gew.-%, noch mehr bevorzugt 8 bis 40 Gew.-%, insbesondere 10 bis 30 Gew.-%,
• – Lysozym und/oder Bovine serum albumin (BSA) und/oder Yoghurt Protein in einer Gesamtmenge von insgesamt 0,05 bis 20 Gew.-%, vorzugsweise 0,1 bis 15 Gew.-%, bevorzugt 0,3 bis 10 Gew.-%, weiter bevorzugt 0,5 bis 7 Gew.-%, noch weiter bevorzugt 0,8 bis 5 Gew.-%, insbesondere 1 bis 3 Gew.-%,
• – 15 bis 75 Gew.-%, vorzugsweise 25 bis 60 Gew.-%, bevorzugt 30 bis 55 Gew.-%, insbesondere 35 bis 50 Gew.-% Wasser

enthalten. In another preferred embodiment, the antiperspirant cosmetic agents according to the invention are characterized in that they are formulated as a water-in-oil emulsion and, based on the total weight of the antiperspirant cosmetic agent according to the invention,

• - At least one antiperspirant aluminum salt in a total amount of 2 to 75 wt .-%, preferably 3 to 70 wt .-%, preferably 4 to 65 wt .-%, more preferably 5 to 55 wt .-%, still more preferably 8 bis 40% by weight, in particular 10 to 30% by weight,
• Lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein in a total amount of 0.05 to 20 wt.%, Preferably 0.1 to 15 wt.%, Preferably 0.3 to 10 wt. -%, more preferably 0.5 to 7 wt .-%, even more preferably 0.8 to 5 wt .-%, in particular 1 to 3 wt .-%,
• - 15 to 75 wt .-%, preferably 25 to 60 wt .-%, preferably 30 to 55 wt .-%, in particular 35 to 50 wt .-% water

contain.

• – mindestens ein schweißhemmendes Aluminiumsalz in einer Gesamtmenge von 2 bis 75 Gew.-%, vorzugsweise 3 bis 70 Gew.-%, bevorzugt 4 bis 65 Gew.-%, weiter bevorzugt 5 bis 55 Gew.-%, noch mehr bevorzugt 8 bis 40 Gew.-%, insbesondere 10 bis 30 Gew.-%,
• – Lysozym und/oder Bovine serum albumin (BSA) und/oder Yoghurt Protein in einer Gesamtmenge von insgesamt 0,05 bis 20 Gew.-%, vorzugsweise 0,1 bis 15 Gew.-%, bevorzugt 0,3 bis 10 Gew.-%, weiter bevorzugt 0,5 bis 7 Gew.-%, noch weiter bevorzugt 0,8 bis 5 Gew.-%, insbesondere 1 bis 3 Gew.-%,
• – 15 bis 90 Gew.-%, vorzugsweise 25 bis 80 Gew.-%, bevorzugt 30 bis 75 Gew.-%, insbesondere 40 bis 60 Gew.-% Wasser, und
• – gegebenenfalls 0,01 bis 2 Gew.-%, vorzugsweise 0,1 bis 1 Gew.-%, bevorzugt 0,2 bis 0,7 Gew.-%, insbesondere 0,3 bis 0,5 Gew.-% einer ein Hydrogel bildenden Substanz

enthalten. In a further preferred embodiment, the antiperspirant cosmetic agents according to the invention are characterized in that they are formulated as an oil-in-water emulsion and, based on the total weight of the antiperspirant cosmetic agent according to the invention,

• - At least one antiperspirant aluminum salt in a total amount of 2 to 75 wt .-%, preferably 3 to 70 wt .-%, preferably 4 to 65 wt .-%, more preferably 5 to 55 wt .-%, still more preferably 8 bis 40% by weight, in particular 10 to 30% by weight,
• Lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein in a total amount of 0.05 to 20 wt.%, Preferably 0.1 to 15 wt.%, Preferably 0.3 to 10 wt. -%, more preferably 0.5 to 7 wt .-%, even more preferably 0.8 to 5 wt .-%, in particular 1 to 3 wt .-%,
• From 15 to 90% by weight, preferably from 25 to 80% by weight, preferably from 30 to 75% by weight, in particular from 40 to 60% by weight, of water, and
• Optionally 0.01 to 2 wt .-%, preferably 0.1 to 1 wt .-%, preferably 0.2 to 0.7 wt .-%, in particular 0.3 to 0.5 wt .-% of a Hydrogel-forming substance

contain.

A second object of the present invention is the use of a combination of at least one selected from the group of cosmetic oils which are liquid at 20 ° C and 1013 hPa, fragrances and waxes, at least one antiperspirant aluminum salt in a total amount of 0.1 to 80% by weight, based on the total weight of the combination, and lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein, to reduce and / or prevent perspiration. The term "combination" in the sense of the present invention also encompasses a mixture of the at least one substance and the antiperspirant aluminum salt with lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein. As regards the use of the abovementioned combination, what has been said about the antiperspirant cosmetic agents according to the invention applies mutatis mutandis.

Furthermore, a third aspect of the present invention is a non-therapeutic cosmetic method for preventing and / or reducing the transpiration of the body, comprising an antiperspirant cosmetic agent containing at least one selected from the group of cosmetic oils, which at 20 ° C and 1,013 hPa are liquid, fragrances and waxes, at least one antiperspirant aluminum salt in a total amount of from 0.1 to 80% by weight, based on the total weight of the antiperspirant cosmetic, and lysozyme and / or bovine serum albumin (BSA) and / or or yoghurt protein, is applied to the skin, especially to the skin of the underarms. With regard to the method according to the invention, mutatis mutandis applies to the said antiperspirant cosmetic agents according to the invention and the use according to the invention.

Finally, a fourth subject of the present invention is the use of lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein to enhance the closure of the sweat gland (s) and / or to occlude the sweat gland (s).

Closure of the sweat gland (s) according to the invention is the formation of a hydrogel and / or precipitate of the at least one antiperspirant aluminum salt and lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein in the excretory duct of the sweat gland or the excretory ducts of the sweat glands to understand. For the purposes of the present invention, occlusion is also understood as meaning the support of the formation of a precipitate of the antiperspirant aluminum salt by the addition of lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein. This occlusion avoids or reduces secretion of sweat from the duct. With regard to the use according to the invention of lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein, the statements made on the cosmetic antiperspirant compositions according to the invention apply mutatis mutandis.

Furthermore, it is also possible in the context of the present invention to dry a liquid mixture of the at least one antiperspirant aluminum salt with lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein. The drying of this mixture can be carried out, for example, by means of conventional drying methods, such as spray drying. The powders obtained in this way are excellent storage and have a long shelf life.

The following examples illustrate the present invention without, however, limiting it to:

Examples:

Determination of hydrogel formation upon addition of lysozyme, bovine serum albumin (BSA) or yoghurt protein to a solution containing an antiperspirant aluminum salt is carried out as follows:
In a beaker, 100 ml of demineralized water are introduced and then added to 35 ml of a solution indicated in Table 1. Subsequently, the pH of the solution is adjusted to 6.5 to 6.6 by adding a 2% sodium bicarbonate solution with stirring. Immediately after adjusting the pH, the turbidity of the solution is measured with a Methrom Optrode 6.1115.000 at a wavelength of 574 nm (green-yellow) in mV (resolution 0.1 mV). The higher the turbidity of the solution, the lower the measured value obtained in mV. Table 1: Solutions for turbidity measurement (in% by weight) VI EGG** E-III ** EV ** Aluminum chlorohydrate (ACH) 10 10 10 10 lysozyme - 2 - - Bovine serum albumin (BSA) - - 2 - Yogurt protein - - - 2 ** according to the invention

For the turbidity at pH values between 6.5 and 6.6, the values given in Table 2 are obtained, the difference between the turbidity before the adjustment of the pH with sodium bicarbonate and after addition of the sodium bicarbonate solution in the following table ( Δ turbidity [mV] = turbidity start - turbidity pH 6.5 to 6.6). Each measurement is carried out twice and from this the mean value is formed Δ turbidity [mV] VI 257 EGG 266 E-II 346 E-III 271

The addition of lysozyme, bovine serum albumin (BSA) and the yoghurt protein to an aluminum chlorohydrate solution at a pH of 6.5 to 6.6 in samples EI, E-II and E-III of the present invention results in significantly higher turbidity, respectively Hydrogel formation as in comparative sample VI. Thus, by the addition of lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein enhances hydrogel formation and thus ensures effective occlusion of the excretory ducts of the sweat glands. Antiperspirant suspension sticks according to the invention (amounts in% by weight) 1 2 3 4 5 6 Hydrogenated Castor Oil - - - 1.5 1.5 1.5 Stearyl Alcohol 24.0 24.0 24.0 18 18 18 Novata AB - - - 4 4 4 Powder of ACH and Lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein (spray dried, contains 10% by weight lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein) 22.0 22.0 22.0 17.6 17.6 17.6 PPG-14 butyl ether 10.0 10.0 10.0 15.3 15.3 15.3 hardened castor oil (eg Cutina HR) 3.0 3.0 3.0 - - - myristate 1.5 1.5 1.5 - - - DL-Menthol 0.2 0.2 0.2 - - - eucalyptol 0.2 0.2 0.2 - - - anethole 0.2 0.2 0.2 - - - Silica dimethyl silylates 1.4 1.4 1.4 - - - silica 0.3 0.3 0.3 - - - talc - - - 3 3 3 Emulgin B1 - - - 3 3 3 Perfume 2.0 2.0 2.0 1 1 1 Cyclomethicone (at least 95% by weight cyclopentasiloxane) ad 100 ad 100 ad 100 ad 100 ad 100 ad 100 Antiperspirant sticks according to the invention in the form of an oil-in-water emulsion (amounts in% by weight) 7 8th Cutina ^® AGS 2.5 2.5 Cutina ^® FS45 3.5 3.5 Eumulgin ^® B2 0.8 0.8 Eumulgin ^® B3 0.8 0.8 diisopropyl 6.0 6.0 Novata ^® AB 4.0 4.0 Cutina ^® CP 5.0 5.0 Cutina ^® HR 4.0 4.0 Kester wax K62 5.0 5.0 Locron ^® L (ACH solution 50%) 40 40 Talc Pharma G 10 10 Perfume 1.2 1.2 2-Benzylheptan-1-ol - 0.3 Sensiva SC 50 0.6 0.6 Lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein 2.0 3.0 1,2-propanediol 10 10 Water, demineralized ad 100 ad 100 Translucent antiperspirant microemulsions (in% by weight) 9 10 11 Plantar ^® 1200 1.7 1.7 - Plantar ^® 2000 1.1 1.4 2,4 Glycerol monooleate 0.71 0.71 - dioctyl 4.0 4.0 0,090 octyldodecanol 1.0 1.0 0,020 perfume oil 1.0 1.0 1.0 aluminum chlorohydrate 8.0 5.0 5.0 1,2-propylene glycol 5.0 5.0 - glycerin - - 5.0 2-Benzylheptan-1-ol 0.50 - - triethylcitrate - 0.50 0.50 triclosan 0.10 - - Lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein 1.0 2.0 2.5 water ad 100 ad 100 ad 100 Antiperspirant roll-ons (amounts in% by weight) 12 13 14 15 Ethanol 96%, (DEP denatured) 30 30 28 28 Mergital ^® CS 11 2.0 2.0 - - Eumulgin ^® B3 2.0 2.0 2.0 2.0 Emulgin ^® B1 - - 2.0 2.0 Aluminum Chlorohydrate 50% (Locron L) 20 20 16 16 hydroxyethyl 0.50 0.50 0.30 0.30 Lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein 2.5 0.50 2.0 1.5 EDTA - - - 0,050 Cocamidopropyl PG-Dimonium Chloride Phosphate 0.20 - - - perfume oil 0.80 0.80 1.0 1.0 water ad 100 ad 100 ad 100 ad 100

Antiperspirant Wipes (Examples Nos. 17 to 20)

For the embodiment according to the invention as an antiperspirant cloth, a single-layer substrate of 100% viscose having a weight per unit area of 50 g / m ^{2 was applied} to 75 g each of the exemplary emulsions 12 or 13 per square meter or 75 g each of the exemplary compositions 9 and 10, respectively. cut into cloths of suitable size and packed in sachets. Antiperspirant stick in the form of a water-in-oil emulsion (amounts in% by weight) 21 22 Aluminum chlorohydrate 50% in water (Locron L) 35.6 35.6 1,2-propylene glycol 13.0 13.0 cyclohexasiloxane 6.00 6.00 Finsolv TN 8.00 8.00 Abil EM 90 1.20 1.20 Polyethylene wax (MW = 500 g / mol, mp = 83 to 91 ° C) 10.0 10.0 Polyalphaolefin wax (MW = 1800 g / mol, mp = 41 ° C) 0,100 0,100 Lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein 2.00 0,500 EDTA - 0.0500 water 25.0 25.0 Perfume 1.00 1.00 Clear antiperspirant gel (in% by weight) 23 24 cyclopentasiloxane 14.0 14.0 Abil EM 97 3.00 3.00 Ethanol 96% 10.0 10.0 Aluminum chlorohydrate 50% in water (Locron L) 40.0 40.0 1,2-propylene glycol 20.3 20.3 water 11.6 11.6 Lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein 2.00 0,500 EDTA - 0.0750 Perfume 1.00 1.00 The following commercial products were used: commercial product INCI Supplier / Manufacturer Abil EM 90 CETYL PEG / PPG-10/1 dimethicone Evonik Abil EM 97 Bis-PEG / PPG-14/14 dimethicone, cyclomethicone Evonik Cutina ^® CP Cetyl palmitate BASF Cutina ^® FS45 Palmitic Acid, Stearic Acid BASF Cutina ^® HR Hydrogenated Castor Oil BASF Dow ^Corning® 245 cyclopentasiloxane Dow Corning Dow Corning ES-5227 DM Dimethicone, PEG / PPG-18/18 dimethicone in the weight ratio 3: 1 Dow Corning Eumulgin ^® B1 Ceteareth-12 BASF Eumulgin ^® B2 Ceteareth-20 BASF Eumulgin ^® B3 Ceteareth-30 BASF Kester wax K62 Cetearyl behenate Koster Keunen Finsolv TN C12-15 alkyl benzoates Innospec Locron L (AS = 50%) Aluminum Chlorohydrate Clariant Mergital ^® CS 11 Ceteareth-11 BASF Novata ^® AB Cocoglycerides (mp 30-32 ° C) BASF Plantar ^® 1200 LAURYL GLUCOSIDE, approx. 50% AS BASF Plantar ^® 2000 DECYL GLUCOSIDE, approx. 50% AS BASF Sensiva ^® SC 50 2-ethyl hexyl glycerin Schülke & Mayr

QUOTES INCLUDE IN THE DESCRIPTION

This list of the documents listed by the applicant has been generated automatically and is included solely for the better information of the reader. The list is not part of the German patent or utility model application. The DPMA assumes no liability for any errors or omissions.

Cited patent literature

• EP 0308937 A2 [0008]
• EP 0183171 A2 [0008]
• US 4359456 A [0008, 0043]
• EP 0191628 [0008]
• US 3542919A [0008]
• US 3553316 A [0008]
• US 3,991,176 A [0008]
• WO 2005/092795 A1 [0008]
• US 3887692A [0043]
• US 3904741A [0043]
• GB 2048229A [0043, 0044]
• GB 1347950A [0043]
• US 4775528A [0044]
• US 6010688 A [0044, 0046]
• US 6436381 A [0045]
• US Pat. No. 6,649,152 A [0045]
• US 6923952 A [0045]
• US 5643558 A [0047]
• US 6245325 A [0047, 0049, 0049, 0049, 0049]
• US 2571030 A [0048]
• US 4017599A [0048]
• US 6042816 A [0049, 0049, 0049, 0049]
• US Pat. No. 7,105,691 A [0049]
• US 6074632 A [0050, 0051]
• US Pat. No. 6663854 A [0051]
• US 2004/0009133 A1 [0051]
• DE 102006004957 A1 [0073]

Cited non-patent literature

• Kirk-Othmer, "Encyclopedia of Chemical Technology", 3rd Ed., 1979, Vol. 8, pages 913-916 [0073]

Claims (10)

 Antiperspirant cosmetic containing a) at least one substance selected from the group of cosmetic oils which are liquid at 20 ° C. and 1013 hPa, fragrances and waxes, b) at least one antiperspirant aluminum salt in a total amount of 0.1 to 80 wt .-%, based on the total weight of the antiperspirant cosmetic agent, and c) lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein. Antiperspirant cosmetic agent according to claim 1, characterized in that the liquid cosmetic oil at 20 ° C and 1013 hPa selected from the group consisting of (i) volatile cyclic silicone oils, in particular cyclotrisiloxane, cyclotetrasiloxane, cyclopentasiloxane and cyclohexasiloxane, and linear silicone oils having 2 to 10 Siloxane units, especially hexamethyldisiloxane, octamethyltrisiloxane, decamethyltetrasiloxane; (ii) volatile non-silicone oils, especially liquid paraffin oils and isoparaffin oils such as isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane and isoeicosan; (iii) nonvolatile silicone oils, especially higher molecular weight linear polyalkylsiloxanes; (iv) non-volatile non-silicone oils, in particular esters of linear or branched C _2-30 saturated or unsaturated fatty alcohols with linear or branched C _2-30 saturated or unsaturated fatty acids which may be hydroxylated, monohydric C ₈ -C ₂₂ fatty alcohol esters or polyhydric C ₂ -C ₇ hydroxycarboxylic acids, the triethyl citrates, the branched saturated or unsaturated C _6-30 fatty alcohols, the mono-, di- and triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C ₈ - ₃₀ fatty acids , the dicarboxylic acid esters of linear or branched C ₂ -C ₁₀ -alkanols, the addition products of ethylene oxide and / or propylene oxide to mono- or polyhydric C _{3 · 22} -alkanols, which may optionally be esterified, the symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, the esters of dimers of unsaturated C _12-22 fatty acids with one way linear, branched and cyclic C _2-18 -alkanols or C _2-6 -alkanols, the benzoic acid esters of linear or branched C _8-22 -alkanols, such as benzoic acid C _12-15 -alkyl ester and isostearyl benzoate and octyl dodecyl benzoate, the synthetic Hydrocarbons, such as polyisobutene and polydecenes, the alicyclic hydrocarbons; and (v) their mixtures. Antiperspirant cosmetic agent according to one of the preceding claims, characterized in that the antiperspirant aluminum salt in a total amount of 1 to 40 wt .-%, preferably from 3 to 35 wt .-%, preferably from 4 to 32 wt .-%, more preferably from 5 to 28% by weight, more preferably from 8 to 25% by weight, in particular from 12 to 22% by weight, based on the total weight of the antiperspirant cosmetic agent. Antiperspirant cosmetic agent according to one of the preceding claims, characterized in that the antiperspirant aluminum salt is selected from the group of (i) water-soluble astringent inorganic salts of aluminum, in particular aluminum chlorohydrate, aluminum sesquichlorohydrate, aluminum dichlorohydrate, aluminum hydroxide, potassium aluminum sulfate, aluminum bromohydrate, aluminum chloride, aluminum sulfate; (ii) water-soluble astringent organic salts of aluminum, especially aluminum chlorohydrex-propylene glycol, aluminum chlorohydrex-polyethylene glycol, aluminum-propylene glycol complexes, aluminum sesquichlorohydrex-propylene glycol, aluminum sesquichlorohydrex-polyethylene glycol, aluminum-propylene glycol-dichlorhydrex, aluminum-polyethylene glycol-dichlorhydrex, aluminum undecylenoyl collagen amino acid, sodium aluminum lactate Sodium aluminum chlorhydroxyl lactate, aluminum lipoamino acids, aluminum lactate, aluminum chlorohydroxy allantoinate, sodium aluminum chlorohydroxy lactate; and (iii) water-soluble astringent inorganic aluminum-zirconium salts, especially aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium pentachlorohydrate, aluminum zirconium octachlorohydrate; (iv) water-soluble astringent organic aluminum-zirconium salts, especially aluminum zirconium-propylene glycol complexes, aluminum zirconium trichlorohydrex glycine, aluminum zirconium tetrachlorohydrex glycine, aluminum zirconium pentachlorohydrex glycine, aluminum zirconium octachlorohydrex glycine; and (v) their mixtures. Antiperspirant cosmetic agent according to one of the preceding claims, characterized in that lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein in a total amount of 0.05 to 15 wt .-%, preferably from 0.1 to 10 wt .-%, preferably from 0.3 to 5 wt .-%, further preferably from 0.5 to 7 wt .-%, still more preferably from 0.8 to 5 wt .-%, in particular from 1 to 3 wt .-%, based on the total weight of the antiperspirant cosmetic agent is included. Antiperspirant cosmetic agent according to one of the preceding claims, characterized in that the antiperspirant cosmetic agent has a weight ratio of the antiperspirant aluminum salt to lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein from 40: 1 to 19: 1, preferably from 30 From 1 to 16: 1, preferably from 20: 1 to 15: 1, more preferably from 10: 1 to 13: 1, even more preferably from 9: 1 to 12: 1, in particular from 8: 1 to 1: 1, having. Antiperspirant cosmetic agent according to one of the preceding claims, characterized in that the antiperspirant cosmetic agent contains free water in a total amount of 15 to 96 wt.%, Preferably 25 to 80 wt.%, Preferably 30 to 70 wt. , in particular from 40 to 60 wt .-%, based on the total weight of the antiperspirant cosmetic agent contains.  Use of a combination of at least one antiperspirant aluminum salt in a total amount of 0.1 to 80 wt .-%, based on the total weight of the combination, and lysozyme and / or bovine serum albumin (BSA) and / or yogurt protein, for reducing and / or Prevention of sweat.  A non-therapeutic cosmetic method for preventing and / or reducing transpiration of the body, wherein a antiperspirant cosmetic according to any one of claims 1 to 8 is applied to the skin, in particular to the skin of the armpits.  Use of lysozyme and / or bovine serum albumin (BSA) and / or yoghurt protein for enhancing the closure of the sweat gland (s) and / or for closing the sweat gland (s).